Role : University Professor – Hospital practitioner (PU-PH)

Theme: Pharmacometrics Modeling, AI, and Personalized Medicine

Location : CBRS 2nd floor, Department of Pharmacology, Toxicology, and Pharmacovigilance

Phone number: 05 55 05 61 40 (poste 51078)

Email address: jean-baptiste.woillard@unilim.fr

ResearcherID: C-4315-2016

Keywords: Population Pharmacokinetics, Pharmacometrics, Pharmacogenetics, Machine learning

Jean-Baptiste Woillard has been a Doctor of Pharmacy since 2008. He obtained a Master’s degree in Pharmacology in 2007, followed by a Ph.D. in Pharmacogenetics and Pharmacokinetics in 2011. He is currently a Professor of Medical Pharmacology at the Faculty of Medicine in Limoges and the head of the “Pharmacometrics and Artificial Intelligence” functional unit within the Department of Pharmacology, Toxicology, and Pharmacovigilance (headed by Professor Pierre Marquet) at the CHU of Limoges.

He serves as an advisor to the International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT) and is a former president of the Pharmacometrics Committee. He is also a member of the European Association for Clinical Pharmacology and Therapeutics (EACPT) and the French Society of Pharmacology and Therapeutics (SFPT).

Professor Woillard is the deputy director and conducts his research within the Inserm U1248 unit “Pharmacology & Transplantation” (Inserm being the French National Institute for Health and Medical Research) on the personalization of treatments, mainly concerning immunosuppressants (IS) in organ transplantation. His research focuses on pharmacogenetic and pharmacodynamic studies of IS, the development of original pharmacokinetic models, statistical modeling, and their application to treatment personalization in transplantation. He is also interested in the modeling of antibiotics and their dose individualization.

Since 2019, his research has also focused on the application of machine learning methods to therapeutic drug monitoring and pharmacometrics. In 2020, he received the IFCC-Gérard Siest Young Scientist Award for his remarkable contributions to pharmacogenetics. He is leading a consortium within the framework of the French PEPR, for which he obtained a funding of 1.8 million euros aimed at developing multi-scale pharmacological digital twins.

He has published more than 130 articles in peer-reviewed international scientific journals, delivered over 30 presentations at national and international conferences, and has been invited to give more than 40 academic or industry talks.

Clinical and medical pharmacology

• Since 2023: Professor in the Pharmacology, Toxicology Department, University Hospital of Limoges/ INSERM U1248, University of Limoges, Limoges (France)
• 2014-2023: Associate Professor in the Pharmacology, Toxicology Department, University Hospital of Limoges/ INSERM U1248, University of Limoges, Limoges (France)
• 2010-2014: Assistant Professor in the Pharmacology, Toxicology Department, University Hospital of Limoges/ INSERM U1248, University of Limoges, Limoges (France)
• 2008-2011: PhD at the INSERM U850, University of Limoges, Limoges (France)
• 2004-2008: Pharmacy residency at the University Hospital of Limoges, Limoges (France)
• 2004: PharmD at the University of Toulouse (Faculty of Pharmacy), Toulouse (France)

Received in 2020 the IFCC-Gérard Siest Young Scientist Award for Distinguished Contributions in Pharmacogenetics

Councilor of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT) and past chair of the Pharmacometrics Committee, member of the European Association for Clinical Pharmacology and Therapeutics (EACPT) and of the French Society of Pharmacology and Therapeutics (SFPT).